Guardant Health Statistics
Want to see GH full AI Analyst Report?
Guardant Health (GH) Stock Statistics & Valuation Metrics
Total Valuation
Guardant Health has a market cap or net worth of $19.49B. The enterprise value is $24.64B.
- Market Cap
- $19.49B
- Enterprise Value
- $24.64B
Share Statistics
Guardant Health has 135,285,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 135,285,980
- Owned by Insiders
- 1.85%
- Owned by Institutions
- 95.48%
Financial Efficiency
Guardant Health’s return on equity (ROE) is 4.19 and return on invested capital (ROIC) is -25.07%.
- Return on Equity (ROE)
- 4.19
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -25.07%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- 393.12K
- Profits Per Employee
- -166.64K
- Employee Count
- 2,498
- Asset Turnover
- 0.49
- Inventory Turnover
- 4.06
Valuation Ratios
The current PE Ratio of Guardant Health is -39.40. Guardant Health’s PEG ratio is 2.98.
- PE Ratio
- -39.40
- PS Ratio
- 15.34
- PB Ratio
- -70.63
- Price to FCF
- -84.49
- Price to Operating Cash Flow
- -112.33
- PEG Ratio
- 2.98
Income Statement
In the last 12 months, Guardant Health had revenue of 982.02M and earned -416.28M in profits. Earnings per share was -3.32.
- Revenue
- 982.02M
- Gross Profit
- 633.01M
- Operating Income
- -437.25M
- Pretax Income
- -417.54M
- Net Income
- -416.28M
- EBITDA
- -373.91M
- Earnings Per Share (EPS)
- -3.32
Cash Flow
In the last 12 months, operating cash flow was -173.48M and capital expenditures -58.67M, giving a free cash flow of -232.15M billion.
- Operating Cash Flow
- -173.48M
- Free Cash Flow
- -232.15M
- Free Cash Flow per Share
- -1.73
Dividends & Yields
Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.20%
- Earnings Yield
- -2.52%
Stock Price Statistics
- Beta
- 1.25
- 52-Week Price Change
- 52.62%
- 50-Day Moving Average
- 168.65
- 200-Day Moving Average
- 133.19
- Relative Strength Index (RSI)
- 34.27
- Average Volume (3m)
- 1.97M
Important Dates
Guardant Health upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Guardant Health as a current ratio of 4.84, with Debt / Equity ratio of -1722.08%
- Current Ratio
- 4.84
- Quick Ratio
- 4.56
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- -3.56
- Interest Coverage Ratio
- -112.20
Taxes
In the past 12 months, Guardant Health has paid -1.26M in taxes.
- Income Tax
- -1.26M
- Effective Tax Rate
- 0.00
Enterprise Valuation
Guardant Health EV to EBITDA ratio is -45.45, with an EV/FCF ratio of -86.42.
- EV to Sales
- 15.69
- EV to EBITDA
- -45.45
- EV to Free Cash Flow
- -86.42
- EV to Operating Cash Flow
- -115.65
Balance Sheet
Guardant Health has $1.03B in cash and marketable securities with $1.69B in debt, giving a net cash position of -$664.59M billion.
- Cash & Marketable Securities
- $1.03B
- Total Debt
- $1.69B
- Net Cash
- -$664.59M
- Net Cash Per Share
- -$4.91
- Tangible Book Value Per Share
- -$2.81
Margins
Gross margin is 65.19%, with operating margin of -39.41%, and net profit margin of -37.93%.
- Gross Margin
- 65.19%
- Operating Margin
- -39.41%
- Pretax Margin
- -37.99%
- Net Profit Margin
- -37.93%
- EBITDA Margin
- -34.52%
- EBIT Margin
- -37.59%
Analyst Forecast
The average price target for Guardant Health is $204.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $204.00
- Price Target Upside
- 41.64% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 19
- Revenue Growth Forecast
- 41.69%
- EPS Growth Forecast
- -14.59%
Scores
- Smart Score
- 9
- AI Score
- 47

